GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Interleukin-32 (IL-32) (Natural killer cells protein 4) (Tumor necrosis factor alpha-inducing factor)

 IL32_HUMAN              Reviewed;         234 AA.
P24001; A6NNM0; A8MPX0; B4DJM1; B8Q191; D3DUB0; D3DUB2; Q5VFH7; Q5VFH8;
Q8WV38; Q96GK9;
01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
12-DEC-2006, sequence version 3.
02-JUN-2021, entry version 147.
RecName: Full=Interleukin-32;
Short=IL-32;
AltName: Full=Natural killer cells protein 4;
AltName: Full=Tumor necrosis factor alpha-inducing factor;
Flags: Precursor;
Name=IL32; Synonyms=NK4, TAIF;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, AND VARIANT ASN-152.
PubMed=1729377;
Dahl C.A., Schall R.P., He H., Cairns J.S.;
"Identification of a novel gene expressed in activated natural killer cells
and T cells.";
J. Immunol. 148:597-603(1992).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 2; 3 AND 4), ALTERNATIVE
SPLICING, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
PubMed=15664165; DOI=10.1016/j.immuni.2004.12.003;
Kim S.-H., Han S.-Y., Azam T., Yoon D.-Y., Dinarello C.A.;
"Interleukin-32: a cytokine and inducer of TNFalpha.";
Immunity 22:131-142(2005).
[3]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7).
Mao W., Han W., Salama A., Moldenhauer A.;
"A new variant of interleukin 32.";
Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
TISSUE=Thalamus;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
TISSUE=Stomach;
PubMed=16341674; DOI=10.1007/s00335-005-0075-2;
Oh J.H., Yang J.O., Hahn Y., Kim M.R., Byun S.S., Jeon Y.J., Kim J.M.,
Song K.S., Noh S.M., Kim S., Yoo H.S., Kim Y.S., Kim N.S.;
"Transcriptome analysis of human gastric cancer.";
Mamm. Genome 16:942-954(2005).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15616553; DOI=10.1038/nature03187;
Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
Myers R.M., Rubin E.M., Pennacchio L.A.;
"The sequence and analysis of duplication-rich human chromosome 16.";
Nature 432:988-994(2004).
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
Hunkapiller M.W., Myers E.W., Venter J.C.;
Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
TISSUE=Eye, and Pancreas;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project:
the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
-!- FUNCTION: Cytokine that may play a role in innate and adaptive immune
responses. It induces various cytokines such as TNFA/TNF-alpha and IL8.
It activates typical cytokine signal pathways of NF-kappa-B and p38
MAPK. {ECO:0000269|PubMed:15664165}.
-!- INTERACTION:
P24001; Q6NTF9-3: RHBDD2; NbExp=3; IntAct=EBI-2866752, EBI-17589229;
P24001-2; P49715: CEBPA; NbExp=7; IntAct=EBI-8800907, EBI-1172054;
P24001-2; Q05655: PRKCD; NbExp=7; IntAct=EBI-8800907, EBI-704279;
P24001-3; P24001-2: IL32; NbExp=2; IntAct=EBI-8800897, EBI-8800907;
P24001-4; P24158: PRTN3; NbExp=3; IntAct=EBI-15570379, EBI-465028;
-!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15664165}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=7;
Name=1; Synonyms=Gamma;
IsoId=P24001-1; Sequence=Displayed;
Name=2; Synonyms=Beta;
IsoId=P24001-2; Sequence=VSP_022006;
Name=3; Synonyms=Delta;
IsoId=P24001-3; Sequence=VSP_022005, VSP_022006;
Name=4; Synonyms=Alpha;
IsoId=P24001-4; Sequence=VSP_022006, VSP_022007;
Name=5;
IsoId=P24001-5; Sequence=VSP_022006, VSP_043318;
Name=6;
IsoId=P24001-6; Sequence=VSP_022006, VSP_045785;
Name=7;
IsoId=P24001-7; Sequence=VSP_047855, VSP_047856;
-!- TISSUE SPECIFICITY: Selectively expressed in lymphocytes. Expression is
more prominent in immune cells than in non-immune cells.
{ECO:0000269|PubMed:15664165}.
-!- INDUCTION: Expression increased after activation of T-cells by mitogens
or activation of NK cells by IL2/interleukin-2.
{ECO:0000269|PubMed:1729377}.
---------------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
---------------------------------------------------------------------------
EMBL; M59807; AAA36367.2; -; mRNA.
EMBL; AY495331; AAS80143.1; -; mRNA.
EMBL; AY495332; AAS80144.1; -; mRNA.
EMBL; AY495333; AAS80145.1; -; mRNA.
EMBL; AY495334; AAS80146.1; -; Genomic_DNA.
EMBL; AY495334; AAS80147.1; -; Genomic_DNA.
EMBL; AY495334; AAS80148.1; -; Genomic_DNA.
EMBL; EU339107; ACA50721.1; -; mRNA.
EMBL; AK296143; BAG58883.1; -; mRNA.
EMBL; BM825040; -; NOT_ANNOTATED_CDS; mRNA.
EMBL; AC108134; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471112; EAW85405.1; -; Genomic_DNA.
EMBL; CH471112; EAW85406.1; -; Genomic_DNA.
EMBL; CH471112; EAW85407.1; -; Genomic_DNA.
EMBL; CH471112; EAW85408.1; -; Genomic_DNA.
EMBL; CH471112; EAW85409.1; -; Genomic_DNA.
EMBL; CH471112; EAW85410.1; -; Genomic_DNA.
EMBL; BC009401; AAH09401.1; -; mRNA.
EMBL; BC018782; AAH18782.1; -; mRNA.
EMBL; BC105602; AAI05603.1; -; mRNA.
CCDS; CCDS32377.1; -. [P24001-2]
CCDS; CCDS32378.1; -. [P24001-4]
CCDS; CCDS32379.1; -. [P24001-6]
CCDS; CCDS45394.1; -. [P24001-5]
CCDS; CCDS76811.1; -. [P24001-1]
PIR; I56140; I56140.
RefSeq; NP_001012649.1; NM_001012631.1. [P24001-2]
RefSeq; NP_001012650.1; NM_001012632.1. [P24001-2]
RefSeq; NP_001012651.1; NM_001012633.1. [P24001-4]
RefSeq; NP_001012652.1; NM_001012634.1. [P24001-5]
RefSeq; NP_001012653.1; NM_001012635.1. [P24001-5]
RefSeq; NP_001012654.1; NM_001012636.1. [P24001-6]
RefSeq; NP_001012736.1; NM_001012718.1. [P24001-2]
RefSeq; NP_001295007.1; NM_001308078.1. [P24001-1]
RefSeq; NP_004212.4; NM_004221.4. [P24001-2]
SMR; P24001; -.
BioGRID; 114664; 16.
DIP; DIP-61119N; -.
IntAct; P24001; 6.
iPTMnet; P24001; -.
PhosphoSitePlus; P24001; -.
SwissPalm; P24001; -.
BioMuta; IL32; -.
DMDM; 119364597; -.
jPOST; P24001; -.
MassIVE; P24001; -.
MaxQB; P24001; -.
PeptideAtlas; P24001; -.
PRIDE; P24001; -.
ProteomicsDB; 1618; -.
ProteomicsDB; 54173; -. [P24001-1]
ProteomicsDB; 54174; -. [P24001-2]
ProteomicsDB; 54175; -. [P24001-3]
ProteomicsDB; 54176; -. [P24001-4]
ProteomicsDB; 54177; -. [P24001-5]
ProteomicsDB; 7283; -.
Antibodypedia; 10701; 593 antibodies.
DNASU; 9235; -.
Ensembl; ENST00000008180; ENSP00000008180; ENSG00000008517. [P24001-5]
Ensembl; ENST00000325568; ENSP00000324742; ENSG00000008517. [P24001-2]
Ensembl; ENST00000382213; ENSP00000371648; ENSG00000008517. [P24001-6]
Ensembl; ENST00000396887; ENSP00000380096; ENSG00000008517. [P24001-4]
Ensembl; ENST00000396890; ENSP00000380099; ENSG00000008517. [P24001-1]
Ensembl; ENST00000440815; ENSP00000405063; ENSG00000008517. [P24001-2]
Ensembl; ENST00000444393; ENSP00000411958; ENSG00000008517. [P24001-2]
Ensembl; ENST00000525643; ENSP00000432218; ENSG00000008517. [P24001-2]
Ensembl; ENST00000526464; ENSP00000450364; ENSG00000008517. [P24001-2]
Ensembl; ENST00000528163; ENSP00000432850; ENSG00000008517. [P24001-2]
Ensembl; ENST00000529550; ENSP00000437020; ENSG00000008517. [P24001-2]
Ensembl; ENST00000530538; ENSP00000436929; ENSG00000008517. [P24001-2]
Ensembl; ENST00000530890; ENSP00000433747; ENSG00000008517. [P24001-5]
Ensembl; ENST00000531965; ENSP00000433177; ENSG00000008517. [P24001-3]
Ensembl; ENST00000533097; ENSP00000432917; ENSG00000008517. [P24001-2]
Ensembl; ENST00000534507; ENSP00000431775; ENSG00000008517. [P24001-1]
Ensembl; ENST00000548246; ENSP00000447979; ENSG00000008517. [P24001-7]
Ensembl; ENST00000548476; ENSP00000449483; ENSG00000008517. [P24001-1]
Ensembl; ENST00000548652; ENSP00000446624; ENSG00000008517. [P24001-6]
Ensembl; ENST00000549213; ENSP00000447812; ENSG00000008517. [P24001-4]
Ensembl; ENST00000551122; ENSP00000447496; ENSG00000008517. [P24001-4]
Ensembl; ENST00000552356; ENSP00000446978; ENSG00000008517. [P24001-5]
Ensembl; ENST00000552664; ENSP00000448683; ENSG00000008517. [P24001-2]
Ensembl; ENST00000675975; ENSP00000501913; ENSG00000008517. [P24001-2]
GeneID; 9235; -.
KEGG; hsa:9235; -.
UCSC; uc002ctk.4; human. [P24001-1]
CTD; 9235; -.
DisGeNET; 9235; -.
GeneCards; IL32; -.
HGNC; HGNC:16830; IL32.
HPA; ENSG00000008517; Tissue enhanced (blood, liver, pancreas).
MIM; 606001; gene.
neXtProt; NX_P24001; -.
OpenTargets; ENSG00000008517; -.
PharmGKB; PA128395754; -.
VEuPathDB; HostDB:ENSG00000008517.16; -.
GeneTree; ENSGT00940000167201; -.
InParanoid; P24001; -.
OrthoDB; 1509659at2759; -.
PhylomeDB; P24001; -.
TreeFam; TF341753; -.
PathwayCommons; P24001; -.
Reactome; R-HSA-449836; Other interleukin signaling.
SIGNOR; P24001; -.
BioGRID-ORCS; 9235; 7 hits in 992 CRISPR screens.
ChiTaRS; IL32; human.
GenomeRNAi; 9235; -.
Pharos; P24001; Tbio.
PRO; PR:P24001; -.
Proteomes; UP000005640; Chromosome 16.
RNAct; P24001; protein.
Bgee; ENSG00000008517; Expressed in right lobe of liver and 188 other tissues.
ExpressionAtlas; P24001; baseline and differential.
Genevisible; P24001; HS.
GO; GO:0005829; C:cytosol; TAS:Reactome.
GO; GO:0005615; C:extracellular space; TAS:ProtInc.
GO; GO:0016020; C:membrane; HDA:UniProtKB.
GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
GO; GO:0006952; P:defense response; TAS:ProtInc.
GO; GO:0006955; P:immune response; TAS:ProtInc.
GO; GO:1903901; P:negative regulation of viral life cycle; IDA:ARUK-UCL.
GO; GO:0010628; P:positive regulation of gene expression; IDA:ARUK-UCL.
GO; GO:1905636; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; IDA:ARUK-UCL.
GO; GO:0034346; P:positive regulation of type III interferon production; IDA:ARUK-UCL.
InterPro; IPR028067; IL-32.
Pfam; PF15225; IL32; 1.
1: Evidence at protein level;
Alternative splicing; Cytokine; Reference proteome; Secreted; Signal.
SIGNAL 1..30
/evidence="ECO:0000255"
CHAIN 31..234
/note="Interleukin-32"
/id="PRO_0000021487"
REGION 213..234
/note="Disordered"
/evidence="ECO:0000256|SAM:MobiDB-lite"
VAR_SEQ 1..10
/note="Missing (in isoform 3)"
/evidence="ECO:0000303|PubMed:15664165"
/id="VSP_022005"
VAR_SEQ 19..84
/note="Missing (in isoform 7)"
/evidence="ECO:0000303|Ref.3"
/id="VSP_047855"
VAR_SEQ 19..64
/note="Missing (in isoform 2, isoform 3, isoform 4, isoform
5 and isoform 6)"
/evidence="ECO:0000303|PubMed:14702039,
ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:15664165,
ECO:0000303|PubMed:16341674"
/id="VSP_022006"
VAR_SEQ 65..84
/note="Missing (in isoform 5)"
/evidence="ECO:0000303|PubMed:14702039"
/id="VSP_043318"
VAR_SEQ 85..93
/note="Missing (in isoform 6)"
/evidence="ECO:0000303|PubMed:16341674"
/id="VSP_045785"
VAR_SEQ 94..113
/note="Missing (in isoform 7)"
/evidence="ECO:0000303|Ref.3"
/id="VSP_047856"
VAR_SEQ 154..210
/note="Missing (in isoform 4)"
/evidence="ECO:0000303|PubMed:15664165"
/id="VSP_022007"
VARIANT 152
/note="D -> N"
/evidence="ECO:0000269|PubMed:1729377"
/id="VAR_005506"
CONFLICT 233
/note="S -> L (in Ref. 5; BM825040)"
/evidence="ECO:0000305"
SEQUENCE 234 AA; 26676 MW; 5F339FE2D348A761 CRC64;
MCFPKVLSDD MKKLKARMVM LLPTSAQGLG AWVSACDTED TVGHLGPWRD KDPALWCQLC
LSSQHQAIER FYDKMQNAES GRGQVMSSLA ELEDDFKEGY LETVAAYYEE QHPELTPLLE
KERDGLRCRG NRSPVPDVED PATEEPGESF CDKVMRWFQA MLQRLQTWWH GVLAWVKEKV
VALVHAVQAL WKQFQSFCCS LSELFMSSFQ SYGAPRGDKE ELTPQKCSEP QSSK


Related products :

Catalog number Product name Quantity
18-783-75588 RABBIT ANTI HUMAN INTERLEUKIN-32 - INTERLEUKIN-32; IL-32; Natural killer cells protein 4; Tumor necrosis factor alpha-inducing factor Polyclonal 0.1 mg
18-783-75589 RABBIT ANTI HUMAN INTERLEUKIN-32 (C-TERMINAL) - INTERLEUKIN-32; IL-32; Natural killer cells protein 4; Tumor necrosis factor alpha-inducing factor Polyclonal 0.1 mg
U1802h CLIA kit Homo sapiens,Human,IL32,IL-32,Interleukin-32,Natural killer cells protein 4,NK4,TAIF,Tumor necrosis factor alpha-inducing factor 96T
U1802h CLIA Homo sapiens,Human,IL32,IL-32,Interleukin-32,Natural killer cells protein 4,NK4,TAIF,Tumor necrosis factor alpha-inducing factor 96T
E1802h ELISA Homo sapiens,Human,IL32,IL-32,Interleukin-32,Natural killer cells protein 4,NK4,TAIF,Tumor necrosis factor alpha-inducing factor 96T
E1802h ELISA kit Homo sapiens,Human,IL32,IL-32,Interleukin-32,Natural killer cells protein 4,NK4,TAIF,Tumor necrosis factor alpha-inducing factor 96T
10-002-38073 Tumor Necrosis Factor-alpha (77-233aa. human) - TNFA. TNFSF2. DIF (differentiation inducing factor ). CACHECTIN; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin N_A 1 mg
20-321-175090 TUMOR NECROSIS FACTOR-ALPHA (TNF-alpha) - MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR-ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclona 0.1 mg
20-321-175108 TUMOR NECROSIS FACTOR ALPHA (TNF-alpha) - BIOTINYLATED MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachec 0.05 mg
20-321-175109 TUMOR NECROSIS FACTOR ALPHA (TNF-alpha) - MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclona 0.1 mg
20-321-175107 TUMOR NECROSIS FACTOR ALPHA (TNF-alpha) - MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclona 0.1 mg
20-321-175089 TUMOR NECROSIS FACTOR-ALPHA (TNF-alpha) - MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR-ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclona 0.1 mg
20-321-175110 TUMOR NECROSIS FACTOR ALPHA (TNF-alpha) - BIOTINYLATED MONOCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR ALPHA (TNF-alpha); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachec 0.05 mg
orb84823 TNF alpha protein Tumor necrosis factor alpha (TNF alpha) is produced by neutrophils, activated lymphocytes, macrophages, NK cells, LAK cells, astrocytes endothelial cells, smooth muscle cells and som 20
20-271-80049 Tumor Necrosis Factor-alpha - Mouse Anti Human Tumor Necrosis Factor-alpha; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclonal 0.5 mg
20-271-80049 Tumor Necrosis Factor-alpha - Mouse Anti Human Tumor Necrosis Factor-alpha; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclonal 1 mg
orb84802 TNF alpha protein Tumor necrosis factor alpha (TNF alpha), also called cachectin, is produced by neutrophils, activated lymphocytes, macrophages, NK cells, LAK cells, astrocytes endothelial cells, smo 50
20-663-48023 Tumor Necrosis Factor-alpha (mAHuTNF-a) - Mouse Anti Human Tumor Necrosis Factor-alpha (mAHuTNF-a); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclonal 1 mg
20-663-48023 Tumor Necrosis Factor-alpha (mAHuTNF-a) - Mouse Anti Human Tumor Necrosis Factor-alpha (mAHuTNF-a); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Monoclonal 0.5 mg
10-663-45249 Tumor Necrosis Factor Receptor Fusion Protein (TNFR) Human - Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; CD120b antigen; Etanercept N 0.05 mg
10-663-45249 Tumor Necrosis Factor Receptor Fusion Protein (TNFR) Human - Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; CD120b antigen; Etanercept N 1 mg
10-663-45249 Tumor Necrosis Factor Receptor Fusion Protein (TNFR) Human - Tumor necrosis factor receptor 2; TNF-R2; Tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; CD120b antigen; Etanercept N 0.01 mg
18-321-177015 TUMOR NECROSIS FACTOR-alpha - POLYCLONAL ANTIBODY TO HUMAN TUMOR NECROSIS FACTOR-alpha; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachectin Polyclonal 0.1 mg
10-321-179006 TUMOR NECROSIS FACTOR ALPHA (E.Coli-DERIVED) - RECOMBINANT MOUSE TUMOR NECROSIS FACTOR ALPHA (E.Coli-DERIVED) (5x104 units); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachec 520 Units
10-321-179009 TUMOR NECROSIS FACTOR ALPHA (E.Coli-DERIVED) - RECOMBINANT HUMAN TUMOR NECROSIS FACTOR ALPHA (E.Coli-DERIVED) (5x104 units); TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-a; Cachec 520 Units
Pathways :
WP1899: Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs)
WP193: Signaling of Hepatocyte Growth Factor Receptor
WP1983: Splicing factor NOVA regulated synpatic proteins
WP1566: Citrate cycle (TCA cycle)
WP927: Signaling of Hepatocyte Growth Factor Receptor
WP94: Signaling of Hepatocyte Growth Factor Receptor
WP444: Signaling of Hepatocyte Growth Factor Receptor
WP1235: Signaling of Hepatocyte Growth Factor Receptor
WP272: Blood Clotting Cascade
WP313: Signaling of Hepatocyte Growth Factor Receptor
WP810: Signaling of Hepatocyte Growth Factor Receptor
WP1531: Vitamin D synthesis
WP1162: Signaling of Hepatocyte Growth Factor Receptor
WP1206: Signaling of Hepatocyte Growth Factor Receptor
WP210: Cytoplasmic Ribosomal Proteins
WP1789: Binding of RNA by Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs)
WP2148: Brain derived neurotrophic factor
WP2199: Seed Development
WP1046: Signaling of Hepatocyte Growth Factor Receptor
WP273: Ovarian Infertility Genes
WP1434: Osteopontin Signaling
WP1690: Propanoate metabolism
WP2218: sGC
WP731: Sterol regulatory element binding protein related
WP1003: Ovarian Infertility Genes

Related Genes :
[IL32 NK4 TAIF] Interleukin-32 (IL-32) (Natural killer cells protein 4) (Tumor necrosis factor alpha-inducing factor)
[Il18 Igif] Interleukin-18 (IL-18) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma)
[Il18 Igif] Interleukin-18 (IL-18) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma)
[IL18 IGIF IL1F4] Interleukin-18 (IL-18) (Iboctadekin) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma)
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[Tnf Tnfa Tnfsf2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[Tnf Tnfa Tnfsf2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[IL18 IGIF] Interleukin-18 (IL-18) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma)
[TRAF2 TRAP3] TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[IL6 IFNB2] Interleukin-6 (IL-6) (B-cell stimulatory factor 2) (BSF-2) (CTL differentiation factor) (CDF) (Hybridoma growth factor) (Interferon beta-2) (IFN-beta-2)
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[IL33 C9orf26 IL1F11 NFHEV] Interleukin-33 (IL-33) (Interleukin-1 family member 11) (IL-1F11) (Nuclear factor from high endothelial venules) (NF-HEV) [Cleaved into: Interleukin-33 (95-270); Interleukin-33 (99-270); Interleukin-33 (109-270)]
[IL18 IGIF] Interleukin-18 (IL-18) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma)
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]
[TNF TNFA TNFSF2] Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]

Bibliography :